Client News

Abivax files registration statement for proposed initial public offering in the United States

Abivax announces the release of its 2023 half-year financial report

Ilmac 2023 in Basel was a resounding success

Affluent Medical: H1 2023 RESULTS – Major advances in clinical programs – Extension of cash horizon to February 2024

AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients

Carbios announces half-year 2023 financial results and corporate update

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

Destiny Pharma: Destiny Pharma: Notice of XF Pipeline Update Meeting

Abivax presents first-half 2023 financial results